methyl 6-allyloxy-2-naphthoate | 364372-11-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: methyl 6-allyloxy-2-naphthoate
• 英文别名: methyl 6-(allyloxy)-2-naphthalate；Methyl 6-prop-2-enoxynaphthalene-2-carboxylate
• CAS: 364372-11-2
• 化学式: C₁₅H₁₄O₃
• 分子量: 242.274
• InChiKey: MZJBHMJFCHVAFK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 6-allyloxy-2-naphthoate 在 sodium chlorite 、 sodium tetrahydroborate 、 四(三苯基膦)钯 、 三氟化硼乙醚 、 氨基磺酸 、 四氯化钛 作用下， 以 四氢呋喃 、 二氯甲烷 、 环己烷 、 水 、 丙酮 为溶剂， 反应 16.5h， 生成 2-Hydroxy-naphthalene-1,6-dicarboxylic acid 1-tert-butyl ester 6-methyl ester
  参考文献：
  名称：

  Utilization of a Peptide Lead for the Discovery of a Novel PTP1B-Binding Motif

  摘要：

  Examination of the PTP1B inhibitory potency of an extensive series of phosphotyrosyl (pTyr) mimetics (Xxx) expressed in the EGFr-derived hexapeptide platform Ac-Asp-Ala-Asp-Xxx-Leu-amide previously led to the finding of high inhibitory potency when Xxx = 4-(phosphono-difluoromethyl)phenylalanyl (F(2)Pmp) (K-i = 0.2 muM) and when Xxx = 3-carboxy-4-carboxy-methyloxyphenylalanyl (K-i = 3.6 muM). In the first instance, further work led from the F(2)Pmp-containing peptide to monomeric inhibitor, 6-(phosphonodifluoromethyl)-2-naphthoic acid (Ki = 22 muM), and to the pseudo-dipeptide mimetic, N-[6-(phosphonodifluoromethyl)-2-naphthoyl]-glutamic acid (K-i = 12 muM). In the current study, a similar approach was applied to the 3-carboxy-4-carboxymethyloxyphenylalanyl-containing peptide, which led to the preparation of monomeric 5-carboxy-6-carboxymethyloxy-2-naphthoic acid (K-i = 900 muM). However, contrary to expectations based on the aforementioned F(2)Pmp work, incorporation of this putative pTyr mimetic into the pseudo-dipeptide, N-[5-carboxy-6-carboxymethyloxy-2-naphthoyl]-glutamic acid, resulted in a substantial loss of binding affinity. A reevaluation of binding orientation for 5-carboxy-6-carboxymethyloxy-2-naphthoic acid was therefore undertaken, which indicated a 180 degrees reversal of the binding orientation within the PTP1B catalytic site. In the new orientation, the naphthyl 2-carboxyl group, and not the o-carboxy carboxymethyloxy groups, mimics a phosphoryl group. Indeed, when 5-carboxy-2-naphthoic acid itself was examined at neutral pH for inhibitory potency, it was found to have K-i = 31 +/- 7 muM, which is lower than parent 5-carboxy-6-carboxymethyloxy-2-naphthoic acid. In this fashion, 5-carboxy-2-naphthoic acid (or more appropriately, 6-carboxy-1-naphthoic acid) has been identified as a novel PTP1B binding motif.

  DOI：

  10.1021/jm010020r
• 作为产物：
  描述：

  2-溴-6-甲氧基萘 在 sodium hydroxide 、 三溴化硼 、 sodium hydride 作用下， 以 乙醇 、 二氯甲烷 、 二甲基亚砜 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.83h， 生成 methyl 6-allyloxy-2-naphthoate
  参考文献：
  名称：

  Utilization of a Peptide Lead for the Discovery of a Novel PTP1B-Binding Motif

  摘要：

  Examination of the PTP1B inhibitory potency of an extensive series of phosphotyrosyl (pTyr) mimetics (Xxx) expressed in the EGFr-derived hexapeptide platform Ac-Asp-Ala-Asp-Xxx-Leu-amide previously led to the finding of high inhibitory potency when Xxx = 4-(phosphono-difluoromethyl)phenylalanyl (F(2)Pmp) (K-i = 0.2 muM) and when Xxx = 3-carboxy-4-carboxy-methyloxyphenylalanyl (K-i = 3.6 muM). In the first instance, further work led from the F(2)Pmp-containing peptide to monomeric inhibitor, 6-(phosphonodifluoromethyl)-2-naphthoic acid (Ki = 22 muM), and to the pseudo-dipeptide mimetic, N-[6-(phosphonodifluoromethyl)-2-naphthoyl]-glutamic acid (K-i = 12 muM). In the current study, a similar approach was applied to the 3-carboxy-4-carboxymethyloxyphenylalanyl-containing peptide, which led to the preparation of monomeric 5-carboxy-6-carboxymethyloxy-2-naphthoic acid (K-i = 900 muM). However, contrary to expectations based on the aforementioned F(2)Pmp work, incorporation of this putative pTyr mimetic into the pseudo-dipeptide, N-[5-carboxy-6-carboxymethyloxy-2-naphthoyl]-glutamic acid, resulted in a substantial loss of binding affinity. A reevaluation of binding orientation for 5-carboxy-6-carboxymethyloxy-2-naphthoic acid was therefore undertaken, which indicated a 180 degrees reversal of the binding orientation within the PTP1B catalytic site. In the new orientation, the naphthyl 2-carboxyl group, and not the o-carboxy carboxymethyloxy groups, mimics a phosphoryl group. Indeed, when 5-carboxy-2-naphthoic acid itself was examined at neutral pH for inhibitory potency, it was found to have K-i = 31 +/- 7 muM, which is lower than parent 5-carboxy-6-carboxymethyloxy-2-naphthoic acid. In this fashion, 5-carboxy-2-naphthoic acid (or more appropriately, 6-carboxy-1-naphthoic acid) has been identified as a novel PTP1B binding motif.

  DOI：

  10.1021/jm010020r

文献信息

• [EN] PERFLUOROPOLYETHER GROUP-BEARING SILANE COMPOUND AND COMPOSITION CONTAINING SAME FOR SURFACE TREATMENT<br/>[FR] COMPOSÉ SILANE PORTANT UN GROUPE PERFLUOROPOLYÉTHER ET COMPOSITION LE CONTENANT POUR LE TRAITEMENT DE SURFACE<br/>[KO] 퍼플루오로폴리에테르기 함유 실란 화합물 및 이를 포함하는 표면 처리용 조성물
  申请人：[en]DONGWOO FINE-CHEM CO., LTD.;[ko]동우 화인켐 주식회사

  公开号：WO2023158223A1

  公开（公告）日：2023-08-24

  본 발명은 아릴렌 골격을 갖는 퍼플루오로폴리에테르기 함유 실란 화합물을 제공한다. 본 발명에 따른 아릴렌 골격을 갖는 퍼플루오로폴리에테르기 함유 실란 화합물은 초기 접촉각을 높일 뿐만 아니라 내마모성을 향상시킬 수 있다. 따라서, 본 발명에 따른 아릴렌 골격을 갖는 퍼플루오로폴리에테르기 함유 실란 화합물은 방오성 코팅제 또는 방수성 코팅제과 같은 표면 처리제로서 유리하게 사용될 수 있다.
• Utilization of a Peptide Lead for the Discovery of a Novel PTP1B-Binding Motif
  作者：Yang Gao、Johannes Voigt、He Zhao、Godwin C. G. Pais、Xuechun Zhang、Li Wu、Zhong-Yin Zhang、Terrence R. Burke

  DOI：10.1021/jm010020r

  日期：2001.8.1

  Examination of the PTP1B inhibitory potency of an extensive series of phosphotyrosyl (pTyr) mimetics (Xxx) expressed in the EGFr-derived hexapeptide platform Ac-Asp-Ala-Asp-Xxx-Leu-amide previously led to the finding of high inhibitory potency when Xxx = 4-(phosphono-difluoromethyl)phenylalanyl (F(2)Pmp) (K-i = 0.2 muM) and when Xxx = 3-carboxy-4-carboxy-methyloxyphenylalanyl (K-i = 3.6 muM). In the first instance, further work led from the F(2)Pmp-containing peptide to monomeric inhibitor, 6-(phosphonodifluoromethyl)-2-naphthoic acid (Ki = 22 muM), and to the pseudo-dipeptide mimetic, N-[6-(phosphonodifluoromethyl)-2-naphthoyl]-glutamic acid (K-i = 12 muM). In the current study, a similar approach was applied to the 3-carboxy-4-carboxymethyloxyphenylalanyl-containing peptide, which led to the preparation of monomeric 5-carboxy-6-carboxymethyloxy-2-naphthoic acid (K-i = 900 muM). However, contrary to expectations based on the aforementioned F(2)Pmp work, incorporation of this putative pTyr mimetic into the pseudo-dipeptide, N-[5-carboxy-6-carboxymethyloxy-2-naphthoyl]-glutamic acid, resulted in a substantial loss of binding affinity. A reevaluation of binding orientation for 5-carboxy-6-carboxymethyloxy-2-naphthoic acid was therefore undertaken, which indicated a 180 degrees reversal of the binding orientation within the PTP1B catalytic site. In the new orientation, the naphthyl 2-carboxyl group, and not the o-carboxy carboxymethyloxy groups, mimics a phosphoryl group. Indeed, when 5-carboxy-2-naphthoic acid itself was examined at neutral pH for inhibitory potency, it was found to have K-i = 31 +/- 7 muM, which is lower than parent 5-carboxy-6-carboxymethyloxy-2-naphthoic acid. In this fashion, 5-carboxy-2-naphthoic acid (or more appropriately, 6-carboxy-1-naphthoic acid) has been identified as a novel PTP1B binding motif.